Morphologic and molecular neuropathology of Alzheimer's disease;Neuropathologie morphologique et moléculaire de la maladie d'Alzheimer

Annales Pharmaceutiques Francaises

Volumn 67, Issue 2, 2009, Pages 127-135

  Duyckaerts, C ^a,b   Panchal, M ^a,b   Delatour, B ^b   Potier, M C ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

Author keywords

A peptide; Alzheimer disease; Neurofibrillary tangle; Neuropathology; Senile plaque; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN STEM; CEREBELLUM; DENDRITE; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HIPPOCAMPUS; HUMAN; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NERVE CELL; NERVE FIBER DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OLFACTORY CORTEX; PATHOLOGICAL ANATOMY; PROTEIN AGGREGATION; PROTEIN METABOLISM; SENILE PLAQUE; SYMPTOM; TAUOPATHY;

AGED; ALZHEIMER DISEASE; BRAIN; HUMANS; MENTAL PROCESSES; NEURONS;

EID: 68649089942     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2009.01.001     Document Type: Article

References (63)

1. Kidd M. Paired helical filaments in electron microscopy in Alzheimer's disease. Nature 197 (1963) 262-268
2. Brion J.P., Passareiro H., Nunez J., and Flament-Durand J. Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer. Arch Biol (Brux) 95 (1985) 229-235
3. Delacourte A., Flament S., Dibe E.M., Hublau P., Sablonniere B., Hemon B., et al. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins. Acta Neuropathol 80 (1990) 111-117
4. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., and Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein Tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. Embo J 8 (1989) 393-399
5. Braak H., and Braak E. Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol 14 (1988) 39-44
6. Schmidt M., Lee V., and Trojanowski J. Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque, neurites and neuropil threads. Lab Invest 64 (1991) 352-357
7. Divry P. Étude histochimique des plaques séniles. J Belge Neurol Psych 9 (1927) 643-657
8. Glenner G.G. Amyloid deposits and amyloidosis. The ß-fibrilloses. N Engl J Med 302 (1980) 1283-1292 1333-1343
9. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120 (1984) 885-890
10. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
11. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the ß-amyloid precursor protein gene. Nature 353 (1991) 844-846
12. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 (1999) 735-741
13. Edbauer D., Winkler E., Regula J.T., Pesold B., Steiner H., and Haass C. Reconstitution of gamma-secretase activity. Nat Cell Biol 5 (2003) 486-488
14. Munter L.M., Voigt P., Harmeier A., Kaden D., Gottschalk K.E., Weise C., et al. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. Embo J 26 (2007) 1702-1712
15. Sergeant N., Bombois S., Ghestem A., Drobecq H., Kostanjevecki V., Missiaen C., et al. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem 85 (2003) 1581-1591
16. Delaère P., Duyckaerts C., He Y., Piette F., and Hauw J.-J. Subtypes and differential laminar distributions of ßA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol (Berl) 81 (1991) 328-335
17. Metsaars W.P., Hauw J.J., Welsem M.E., and Duyckaerts C. A grading system of Alzheimer disease lesions in neocortical areas. Neurobiol Aging 24 (2003) 563-572
18. Arends Y.M., Duyckaerts C., Rozemuller J.M., Eikelenboom P., and Hauw J.-J. Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging 21 (2000) 39-47
19. Wegiel J., Wang K.C., Tarnawski M., and Lach B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plaque degradation. Acta Neuropathol (Berl) 100 (2000) 356-364
20. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
21. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide: the first step of a fatal cascade. J Neurochem 91 (2004) 513-520
22. Wegiel J., Kuchna I., Nowicki K., Frackowiak J., Mazur-Kolecka B., Imaki H., et al. Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol (Berl) 113 (2007) 389-402
23. Thal D.R., Capetillo-Zarate E., Schultz C., Rub U., Saido T.C., Yamaguchi H., et al. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Acta Neuropathol 110 (2005) 459-471
24. Jiang Q., Lee C.Y., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 58 (2008) 681-693
25. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 (1991) 239-259
26. Thal D.R., Rub U., Orantes M., and Braak H. Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58 (2002) 1791-1800
27. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41 (1997) 17-24
28. Grignon Y., Duyckaerts C., Bennecib M., and Hauw J.-J. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol (Berl) 95 (1998) 395-406
29. Cras P., Smith M.A., Richey P.L., Siedlak S.L., Mulvihill P., and Perry G. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol (Berl) 89 (1995) 291-295
30. Cotman C.W. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease. Neurobiol Aging 19 (1998) S29-32
31. Stadelmann C., Deckwerth T.L., Srinivasan A., Bancher C., Bruck W., Jellinger K., et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease: evidence for apoptotic cell death. Am J Pathol 155 (1999) 1459-1466
32. Rohn T.T., Head E., Su J.H., Anderson A.J., Bahr B.A., Cotman C.W., et al. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol 158 (2001) 189-198
33. Nagy Z., Esiri M.M., and Smith A.D. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience 87 (1998) 731-739
34. Duyckaerts C., Colle M.A., Seilhean D., and Hauw J.-J. Laminar spongiosis of the dentate gyrus: a sign of disconnection, present in cases of Alzheimer disease. Acta Neuropathol (Berl) 95 (1998) 413-420
35. Terry D., Masliah E., and Hansen L.A. Structural basis of the cognitive alterations in Alzheimer disease. In: Terry R.D., Katzman R., and Bick K.L. (Eds). Alzheimer disease (1994), Raven Press, New York 179-196
36. Scheff S.W., and Price D.A. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 9 (2006) 101-115
37. Masliah E., Terry R.D., DeTeresa R.M., and Hansen L.A. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 103 (1989) 234-239
38. Shimohama S., Kamiya S., Taniguchi T., Akagawa K., and Kimura J. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease. Biochem Biophys Res Commun 236 (1997) 239-242
39. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., and Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16 (1995) 285-304
40. Mattson M., Keller J., and Begley J. Evidence for synaptic apoptosis. Exp Neurol 153 (1998) 35-48
41. Duyckaerts C., Bennecib M., Grignon Y., Uchihara T., He Y., Piette F., et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 18 (1997) 267-273
42. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18 (1997) 351-357
43. Duyckaerts C., and Hauw J.-J. Prevalence, incidence and duration of Braak's stages in the general population: can we know?. Neurobiol Aging 18 (1997) 362-369
44. Neuropathology group of the medical research council cognitive function and ageing study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
45. Duyckaerts C., Potier M.C., and Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol 115 (2008) 5-38
46. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383 (1996) 710-713
47. Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O., van der Kolk N., et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165 (2004) 1289-1300
48. Herzig M.C., Van Nostrand W.E., and Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 16 (2006) 40-54
49. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6 (2000) 143-150
50. Farris W., Schutz S.G., Cirrito J.R., Shankar G.M., Sun X., George A., et al. Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. J Neurosci 27 (2007) 2866-2875
51. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Nat Med 4 (1998) 97-100
52. Van Dam D., D'Hooge R., Staufenbiel M., Van Ginneken C., Van Meir F., and De Deyn P.P. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17 (2003) 388-396
53. Howlett D.R., Richardson J.C., Austin A., Parsons A.A., Bate S.T., Davies D.C., et al. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res 1017 (2004) 130-136
54. Bizon J., Prescott S., and Nicolle M.M. Intact spatial learning in adult Tg2576 mice. Neurobiol Aging 28 (2007) 440-446
55. Blanchard J., Martel G., Guillou J.L., Nogues X., and Micheau J. Impairment of spatial memory consolidation in APP(751SL) mice results in cue-guided response. Neurobiol Aging (2007) (Published ahead of print)
56. Cheng I.H., Scearce-Levie K., Legleiter J., Palop J.J., Gerstein H., Bien-Ly N., et al. Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282 (2007) 23818-23828
57. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22 (2002) 1858-1867
58. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., Kaeser S., Schaefer C., Kilger E., et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313 (2006) 1781-1784
59. Orgogozo J.M., Gilman S., Dartigues J.F., Laurent B., Puel M., Kirby L.C., et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61 (2003) 46-54
60. Delatour B., Blanchard V., Pradier L., and Duyckaerts C. The innervation of senile plaques: a link between amyloid and neurofibrillary pathology?. In: Gauthier S., Scheltens P., and Cummings J.L. (Eds). Alzheimer's disease and related disorders. Annual 2004 (2003), Martin Dunitz, London 1-19
61. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
62. Probst A., Gotz J., Wiederhold K.H., Tolnay M., Mistl C., Jaton A.L., et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (Berl) 99 (2000) 469-481
63. Langui D., Lachapelle F., and Duyckaerts C. Animal models of neurodegenerative diseases. Med Sci (Paris) 23 (2007) 180-186